Table 3.
Demographic features, clinicopathologic findings, and clinical outcomes for 45 cats with urinary incontinence categorized by anatomic lesion localization
| Feature | Spinal cord | Bladder | Urethra | Ureter | P‐value |
|---|---|---|---|---|---|
| Number | 18/45 (40%) | 9/45 (20%) | 17/45 (38%) | 1/45 (2%) | NA |
| Sex | 8 M (44%) | 2 M (22%) | 17 M (67%) | 0 M (0%) | <.04 |
| 10 F (56%) | 7 F (78%) | 8 F (33%) | 1 F (100%) | ||
| Breed | 16 Mixed (89%) | 7 Mixed (78%) | 17 Mixed (100%) | 1 Mixed (100%) | NS |
| 2 Purebred (11%) | 2 Purebred (22%) | 0 Purebred (0%) | Purebred (0%) | ||
| Age, median (IQR), mo | 35 (7‐86) | 174 (90‐199) | 29 (8‐82) | 34 (NA) | <.01 |
| Duration of signs, median (IQR), d | 22 (1‐198) | 21.5 (1‐112.5) | 105 (10.3‐180) | 920 (NA) | NS |
| Other neurologic signs | 15 (83%) | 1 (11%) | 3 (18%) | 0 (0%) | <.001 |
| SCr, median (IQR), mg/dL | 1.3 (1.1‐1.4) | 1.5 (1.4‐2.3) | 1.2 (1.0‐1.4) | 2.2 (NA) | NS |
| USG, median (IQR) | 1.047 (1.024‐1.057) | 1.029 (1.019‐1.047) | 1.047 (1.034‐1.053) | 1.056 (NA) | NS |
| Urine culture positive | 2/9 (22%) | 2/5 (40%) | 6/13 (46%) | 1/1 (100%) | NS |
| Favorable outcome | 3/17 (18%) | 7/8 (88%) | 9/13 (69%) | NR | <.04 |
Abbreviations: F, female; IQR, interquartile range; M, male; NA, not applicable; NR, not reported; SCr, serum creatinine; USG, urine specific gravity.